NANOGROUP
Research NANOGROUP (NNG.WA) on Bullrun: market cap PLN 103.38M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNNG.WA
- ExchangeXWAR
- CountryPoland
- SectorHealthcare
- IndustryBiotechnology
- CurrencyPLN
- Market capPLN 103.38M
- Financial periodQ1 2026
- RevenuePLN 0
- Net income-PLN 2.24M
- Free cash flow-PLN 3.65M
Valuation Snapshot
latest market cap is PLN 103.38M.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-05 | PLN 103.38M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 PLN.
About NANOGROUP
NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantation. NanoGroup S.A.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is NANOGROUP's market cap?
NANOGROUP's market capitalization is PLN 103.38M.
What does NANOGROUP do?
NanoGroup S.A. operates as a biotechnology company in Poland. It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences. The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantation. NanoGroup S.A. was incorporated in 2016 and is based in Warsaw, Poland.